These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

634 related items for PubMed ID: 22712526

  • 1. Does risk for ovarian malignancy algorithm excel human epididymis protein 4 and CA125 in predicting epithelial ovarian cancer: a meta-analysis.
    Li F, Tie R, Chang K, Wang F, Deng S, Lu W, Yu L, Chen M.
    BMC Cancer; 2012 Jun 19; 12():258. PubMed ID: 22712526
    [Abstract] [Full Text] [Related]

  • 2. Diagnostic measures comparison for ovarian malignancy risk in Epithelial ovarian cancer patients: a meta-analysis.
    Suri A, Perumal V, Ammalli P, Suryan V, Bansal SK.
    Sci Rep; 2021 Aug 27; 11(1):17308. PubMed ID: 34453074
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Comparison of serum cancer antigen 125, human epididymis protein 4, ROMA, and CPH-I for diagnosis of ovarian cancer in Chinese patients with ovarian mass].
    Shipeng G, Yongning C, Yadi Z, Chanyuan LI, Qifan J.
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Dec 30; 39(12):1393-1401. PubMed ID: 31907150
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of HE4, CA125, and Risk of Ovarian Malignancy Algorithm in the Prediction of Ovarian Cancer in Korean Women.
    Cho HY, Park SH, Park YH, Kim HB, Kang JB, Hong SH, Kyung MS.
    J Korean Med Sci; 2015 Dec 30; 30(12):1777-83. PubMed ID: 26713052
    [Abstract] [Full Text] [Related]

  • 10. HE4, CA125, the Risk of Malignancy Algorithm and the Risk of Malignancy Index and complex pelvic masses - a prospective comparison in the pre-operative evaluation of pelvic masses in an Australian population.
    Richards A, Herbst U, Manalang J, Pather S, Saidi S, Tejada-Berges T, Tan K, Williams P, Carter J.
    Aust N Z J Obstet Gynaecol; 2015 Oct 30; 55(5):493-7. PubMed ID: 26172511
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass.
    Karlsen MA, Sandhu N, Høgdall C, Christensen IJ, Nedergaard L, Lundvall L, Engelholm SA, Pedersen AT, Hartwell D, Lydolph M, Laursen IA, Høgdall EV.
    Gynecol Oncol; 2012 Nov 30; 127(2):379-83. PubMed ID: 22835718
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of HE4, CA125 and ROMA algorithm in women with a pelvic mass: correlation with pathological outcome.
    Sandri MT, Bottari F, Franchi D, Boveri S, Candiani M, Ronzoni S, Peiretti M, Radice D, Passerini R, Sideri M.
    Gynecol Oncol; 2013 Feb 30; 128(2):233-8. PubMed ID: 23200911
    [Abstract] [Full Text] [Related]

  • 15. CPH-I and HE4 Are More Favorable Than CA125 in Differentiating Borderline Ovarian Tumors from Epithelial Ovarian Cancer at Early Stages.
    Wang Z, Tao X, Ying C.
    Dis Markers; 2019 Feb 30; 2019():6241743. PubMed ID: 31737130
    [Abstract] [Full Text] [Related]

  • 16. The performance of Carbohydrate Antigen 125-Thomsen-nouveau and anti-Müllerian hormone combined with CA125, Human epididymis protein 4 and Risk of Malignancy Algorithm in diagnosis for patients with Epithelial ovarian cancer.
    Hou X, Liu S, Liu J, Zhou J, Liang Y, Cui L.
    Clin Biochem; 2023 Sep 30; 119():110615. PubMed ID: 37517433
    [Abstract] [Full Text] [Related]

  • 17. Significance of Serum Human Epididymis Protein 4 and Cancer Antigen 125 in Distinguishing Type I and Type II Epithelial Ovarian Cancers.
    Yanaranop M, Jantarateptewan N, Tiyayon J, Nakrangsee S.
    Int J Gynecol Cancer; 2018 Jul 30; 28(6):1058-1065. PubMed ID: 29975290
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic Performance of F-18 FDG PET/CT Compared with CA125, HE4, and ROMA for Epithelial Ovarian Cancer.
    Lee SS, Park JS, Lee KB, Jeong DH, Byun JM, Lee SM.
    Asian Pac J Cancer Prev; 2021 Apr 01; 22(4):1123-1127. PubMed ID: 33906304
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.